Symmetry Partners, LLC United Therapeutics Corp Transaction History

Symmetry Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 02, 2024	SELL	$210.76 - $249.51 $6,955 - $8,233	-33 Reduced 0.92%	3,566 $819,000
Q4 2023 Jan 02, 2024	SELL	$214.88 - $256.94 $4,942 - $5,909	-23 Reduced 0.64%	3,599 $789,000
Q4 2022 Jan 06, 2023	BUY	$205.95 - $280.43 $20,595 - $28,043	100 Added 2.84%	3,622 $1.01 Million
Q3 2022 Oct 03, 2022	BUY	$203.3 - $244.17 $112,831 - $135,514	555 Added 18.71%	3,522 $737,000
Q2 2022 Jul 11, 2022	BUY	$174.81 - $241.14 $27,969 - $38,582	160 Added 5.7%	2,967 $699,000
Q3 2021 Oct 18, 2021	SELL	$179.86 - $214.88 $16,906 - $20,198	-94 Reduced 3.24%	2,807 $530,000
Q4 2020 Feb 18, 2021	BUY	$101.87 - $151.79 $35,960 - $53,581	353 Added 13.85%	2,901 $440,000
Q3 2020 Nov 03, 2020	BUY	$99.9 - $121.13 $9,690 - $11,749	97 Added 3.96%	2,548 $257,000
Q2 2020 Jul 20, 2020	BUY	$92.74 - $125.82 $227,305 - $308,384	2,451 New	2,451 $297,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.